7 Mar, 2010 in
News & Articles by
admin
Mesothelioma and Asbestos
Articles, News, and Information – newbFAQLatest
The City of Recent Haven, Connecticut Office of Economic Development is using steps to ensure best environmental sustainability in the form of large-scale recycling. They’ve just launched a recent Contractor Deconstruction Training Program to teach contractors how to disassemble[...]
READ FULL ARTICLE »
Featured
Does anyone know if Peritoneal Mesothelioma has the same awareness color for just Mesothelioma which is Pearl? What is an adenocarcinoma? With the cancer mesothelioma, what effect does metastasis to the lymph nodes have on the patient? Why are Families that Lives have been affected by MESOTHELIOMA able to be compensated but Families of Agent Or? Is there a cure for mesothelioma?
|
The National Comprehensive Cancer Network (NCCN) has announced a recent service called NCCN Flash Updates, which provides email notification to subscribers when updates are published to the NCCN Drugs & Biologics Compendium as well as the NCCN Clinical Practice Guidelines in Oncology. Users currently registered at NCCN.org possess received a complimentary preview of the Flash Updates that notified them of the latest update, the publication of the NCCN Guidelines for Malignant Pleural Mesothelioma (MPM) as an addition to the Total Library of NCCN Guidelines. The Flash Update included information about treatment options for malignant pleural mesothelioma patients as well as first-line therapy regimens. A recent chapter on malignant pleural mesothelioma was as well as added to the NCCN Compendium. Mesothelioma is a rare form of cancer caused by asbestos exposure which attacks the membrane surrounding the lungs, abdomen or heart. Mesothelioma is very resistant to treatment, so recent information is always beneficial. The NCCN Guidelines are updated continually as recent clinical evidence as well as research data becomes available. Flash Updates make it likely for clinicians to possess timely notice of this information so that they can make more informed treatment decisions for their cancer patients. For the filled story, go to PR Inside. |
